Clinical Trial Update: IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 [NA]

View source ↗

Summary

Clinical trial update for the extension protocol of IPI-926 (saridegib) for continuation of treatment; the study involving basal cell carcinoma and chondrosarco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Chondrosarcoma

Drugs mentioned

• saridegib (saridegib)

Snippet

Sponsor: Infinity Pharmaceuticals, Inc. | Conditions: Basal Cell Carcinoma, Chondrosarcoma | NA | Status: COMPLETED